Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 78Recruiting 33Terminated 23Active not recruiting 22Unknown 19Withdrawn 6Not yet recruiting 3Enrolling by invitation 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 15Breast 11Lymphoid 8Thoracic 6Other hematologic neoplasm 6Head & Neck 4Gynecologic 3CNS 3Sarcoma 2Plasma cell 2NET 2Myeloid 2Genitourinary 2Endocrine 2Other 1Dermatologic 1

Conditions

Neuroendocrine Tumors 2Sarcoma 1Lymphoma 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Adenoma, Islet Cell 1

Interventions

PM 01183 1Injections 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Enrolling by invitation × NET × Clear all
NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation
46 enrolled
EndocrineNET

Adenoma, Islet Cell, Neuroendocrine Tumors

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡